Grupp Helen, Kaufmann Claudia, König Hans-Helmut, Bleibler Florian, Wild Beate, Szecsenyi Joachim, Herzog Wolfgang, Schellberg Dieter, Schäfert Rainer, Konnopka Alexander
Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Germany.
Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Germany.
J Psychosom Res. 2017 Jun;97:52-57. doi: 10.1016/j.jpsychores.2017.04.002. Epub 2017 Apr 4.
The aim of this study was to calculate disorder-specific excess costs in patients with functional somatic syndromes (FSS).
We compared 6-month direct and indirect costs in a patient group with FSS (n=273) to a control group of the general adult population in Germany without FSS (n=2914). Data on the patient group were collected between 2007 and 2009 in a randomized controlled trial (speciAL). Data on the control group were obtained from a telephone survey, representative for the general German population, conducted in 2014. Covariate balance between the patient group and the control group was achieved using entropy balancing. Excess costs were calculated by estimating generalized linear models and two-part models for direct costs and indirect costs. Further, we estimated excess costs according to the level of somatic symptom severity (SSS).
FSS patients differed significantly from the control group regarding 6-month costs of outpatient physicians (+€280) and other outpatient providers (+€74). According to SSS, significantly higher outpatient physician costs were found for mild (+€151), moderate (+€306) and severe (+€376) SSS. We also found significantly higher costs of other outpatient providers in patients with mild, moderate and severe SSS. Regarding costs of rehabilitation and hospital treatments, FSS patients did not differ significantly from the control group for any level of SSS. Indirect costs were significantly higher in patients with severe SSS (+€760).
FSS were of major importance in the outpatient sector. Further, we found significantly higher indirect costs in patients with severe SSS.
本研究旨在计算功能性躯体综合征(FSS)患者特定疾病的额外费用。
我们将一组FSS患者(n = 273)的6个月直接和间接费用与德国无FSS的一般成年人群对照组(n = 2914)进行比较。患者组的数据于2007年至2009年在一项随机对照试验(speciAL)中收集。对照组的数据来自2014年进行的一项代表德国一般人群的电话调查。使用熵平衡实现患者组与对照组之间的协变量平衡。通过估计直接费用和间接费用的广义线性模型和两部分模型来计算额外费用。此外,我们根据躯体症状严重程度(SSS)水平估计额外费用。
FSS患者在门诊医生6个月费用(+280欧元)和其他门诊服务提供者费用(+74欧元)方面与对照组有显著差异。根据SSS,轻度(+151欧元)、中度(+306欧元)和重度(+376欧元)SSS患者的门诊医生费用显著更高。我们还发现轻度、中度和重度SSS患者的其他门诊服务提供者费用也显著更高。关于康复和住院治疗费用,FSS患者在任何SSS水平上与对照组均无显著差异。重度SSS患者的间接费用显著更高(+760欧元)。
FSS在门诊部门具有重要意义。此外,我们发现重度SSS患者的间接费用显著更高。